Market Segmentation:
- By Product Type
- Surgical Stapling Devices
- Gastric Bands
- Gastric Balloons
- Gastric Bypass Devices
- Gastric Sleeve Devices
- Others (Malabsorptive Devices, Biliopancreatic Diversion Devices)
- By Procedure Type
- Roux-en-Y Gastric Bypass
- Sleeve Gastrectomy
- Adjustable Gastric Banding
- Biliopancreatic Diversion with Duodenal Switch
- Intragastric Balloon Placement
- Endoscopic Sleeve Gastroplasty
- Others (Revision Surgeries, Single-Anastomosis Duodenal-Ileal Bypass)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others (Military Hospitals, Academic Institutions)
- By Patient Demographics
- Adults (18-64 years)
- Geriatric (65 years and above)
- Pediatric (under 18 years)
- By Material
- Stainless Steel
- Titanium
- Polymers
- Composites
- Others (Ceramics, Biodegradable Materials)
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East, and Africa
Frequently Asked Questions
The current market size of the Bariatric Surgery Devices industry is estimated to be US$ 2.8 billion in 2023.
The key factors driving the growth of the Bariatric Surgery Devices market include the rising prevalence of obesity, increasing awareness of the benefits of bariatric surgery, technological advancements in devices, growing geriatric population, and the expansion of healthcare infrastructure in emerging markets.
The key factors hampering the growth of the Bariatric Surgery Devices Market include the high cost of bariatric surgery procedures, risks and complications associated with the surgeries, lack of reimbursement coverage in certain regions, and social stigma surrounding bariatric surgery.
The leading component segment in the Bariatric Surgery Devices Market is the Surgical Stapling Devices, which are widely used in various bariatric procedures, such as sleeve gastrectomy and Roux-en-Y gastric bypass.
The major players operating in the Bariatric Surgery Devices Market include Medtronic plc, Johnson & Johnson (Ethicon), Olympus Corporation, ReShape Lifesciences Inc., and Apollo Endosurgery, Inc., among others.
The Bariatric Surgery Devices Market is expected to grow at a CAGR of 7.8% from 2024 to 2031, reaching a market size of US$ 5.1 billion by 2031.
The key drivers of the Bariatric Surgery Devices Market include the rising prevalence of obesity, increasing awareness of the benefits of bariatric surgery, technological advancements in bariatric devices, growing geriatric population prone to obesity-related comorbidities, and the expansion of healthcare infrastructure in emerging markets.